| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Cellectar Biosciences files for $300M mixed securities shelf | 4 | Seeking Alpha | ||
| 15.05. | Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q1 2024 Earnings Call Transcript | 2 | Insider Monkey | ||
| 14.05. | Earnings call: Cellectar Biosciences outlines robust WM market strategy | 2 | Investing.com | ||
| 14.05. | Cellectar Biosciences Inc reports results for the quarter ended in March - Earnings Summary | 2 | Reuters | ||
| 14.05. | Cellectar Biosciences Inc Loss At -$21.58 Mln In Q1 | 3 | RTTNews | ||
| 14.05. | Cellectar Biosciences GAAP EPS of -$0.74 misses by $0.18 | 1 | Seeking Alpha | ||
| 14.05. | Cellectar Biosciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.05. | Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update | 63 | GlobeNewswire (Europe) | Management to host a conference call today at 8:30 am ET WM pivotal study data to be announced in June FLORHAM PARK, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB)... ► Artikel lesen | |
| 14.05. | Cellectar Biosciences, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 13.05. | Cellectar Biosciences Q1 2024 Earnings Preview | 2 | Seeking Alpha | ||
| 08.05. | Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day | 1 | GlobeNewswire (USA) | ||
| 07.05. | Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024 | 1 | GlobeNewswire (USA) | ||
| 28.03. | Cellectar Biosciences, Inc. (CLRB) Q4 2023 Earnings Call Transcript | 1 | Insider Monkey | ||
| 28.03. | Earnings call: Cellectar Biosciences outlines growth and NDA plans | 3 | Investing.com | ||
| 27.03. | Cellectar Biosciences Inc reports results for the quarter ended in December - Earnings Summary | 3 | Reuters | ||
| 27.03. | Cellectar Biosciences GAAP EPS of -$3.11 misses by $0.28 | 1 | Seeking Alpha | ||
| 27.03. | Cellectar Biosciences, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 27.03. | Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update | 163 | GlobeNewswire (Europe) | FLORHAM PARK, N.J., March 27, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization... ► Artikel lesen | |
| 27.03. | Cellectar Biosciences, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 26.03. | Cellectar Biosciences FY 2023 Earnings Preview | 1 | Seeking Alpha |
Seite:
1 2 3 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NEL | 4.945 |
| NVIDIA | 2.725 |
| EVOTEC | 1.998 |
| GAMESTOP | 1.851 |
| TUI | 1.644 |
| PLUG POWER | 1.260 |
| BAYER | 1.135 |
| RHEINMETALL | 932 |
| SUPER MICRO COMPUTER | 859 |
| AIXTRON SE | 816 |
| VOLKSWAGEN | 809 |
| BIONTECH | 745 |
| DEUTSCHE LUFTHANSA | 639 |
| SIEMENS ENERGY | 625 |
| BYD | 529 |
| RWE | 523 |
| MERCEDES-BENZ | 512 |
| JINKOSOLAR | 501 |
| TESLA | 500 |
| COMMERZBANK | 488 |
| DEUTSCHE BANK | 448 |
| HELLOFRESH | 448 |
| HEIDELBERGER DRUCK | 438 |
| THYSSENKRUPP NUCERA | 427 |
| RENK GROUP | 425 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
